Ghosal Samit, Sinha Binayak, Majumder Milan, Misra Anoop
Nightingale Hospital, Kolkata, India.
AMRI Hospitals, Kolkata, India.
Diabetes Metab Syndr. 2020 Jul-Aug;14(4):319-323. doi: 10.1016/j.dsx.2020.03.014. Epub 2020 Apr 10.
and aims: To prevent the spread of coronavirus disease (COVID19) total lockdown is in place in India from March 24, 2020 for 21 days. In this study, we aim to assess the impact of the duration of the lockdown on glycaemic control and diabetes-related complications.
A systematic search was conducted using Cochrane library. A simulation model was created using glycemic data from previous disasters (taken as similar in impact to current lockdown) taking baseline HBA1c and diabetes-related complications data from India-specific database. A multivariate regression analysis was conducted to analyse the relationship between the duration of lockdown and glycaemic targets & diabetes-related complications.
The predictive model was extremely robust (R2 = 0.99) and predicted outcomes for period of lockdown up to 90 days. The predicted increment in HBA1c from baseline at the end of 30 days and 45 days lockdown was projected as 2.26% & 3.68% respectively. Similarly, the annual predicted percentage increase in complication rates at the end of 30-day lockdown was 2.8% for non-proliferative diabetic retinopathy, 2.9% for proliferative diabetic retinopathy, 1.5% for retinal photocoagulation, 9.3% for microalbuminuria, 14.2% for proteinuria, 2.9% for peripheral neuropathy, 10.5% for lower extremity amputation, 0.9% for myocardial infarction, 0.5% for stroke and 0.5% for infections.
The duration of lockdown is directly proportional to the worsening of glycaemic control and diabetes-related complications. Such increase in diabetes-related complications will put additional load on overburdened healthcare system, and also increase COVID19 infections in patients with such uncontrolled glycemia.
为防止冠状病毒病(COVID-19)传播,印度自2020年3月24日起实施为期21天的全面封锁。在本研究中,我们旨在评估封锁持续时间对血糖控制和糖尿病相关并发症的影响。
使用Cochrane图书馆进行系统检索。利用以往灾难中的血糖数据(其影响被视为与当前封锁相似)创建模拟模型,并从印度特定数据库获取基线糖化血红蛋白(HBA1c)和糖尿病相关并发症数据。进行多变量回归分析以分析封锁持续时间与血糖目标及糖尿病相关并发症之间的关系。
预测模型极其稳健(R2 = 0.99),并预测了长达90天的封锁期结果。预计封锁30天和45天时,糖化血红蛋白较基线的预测增幅分别为2.26%和3.68%。同样,在30天封锁结束时,非增殖性糖尿病视网膜病变的并发症发生率年度预测增幅为2.8%,增殖性糖尿病视网膜病变为2.9%,视网膜光凝为1.5%,微量白蛋白尿为9.3%,蛋白尿为14.2%,周围神经病变为2.9%,下肢截肢为10.5%,心肌梗死为0.9%,中风为0.5%,感染为0.5%。
封锁持续时间与血糖控制恶化及糖尿病相关并发症直接相关。糖尿病相关并发症的这种增加将给负担过重的医疗系统带来额外负担,并且还会增加血糖控制不佳患者的COVID-19感染。